Language selection

Search

Details for: CEFTAZIDIME FOR INJECTION, USP

Company: FRESENIUS KABI CANADA LTD

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
00886971CEFTAZIDIME FOR INJECTION, USPCEFTAZIDIME1 G / VIALPOWDER FOR SOLUTIONINTRAMUSCULAR
00886971CEFTAZIDIME FOR INJECTION, USPCEFTAZIDIME1 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
00886955CEFTAZIDIME FOR INJECTION, USPCEFTAZIDIME2 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
00886963CEFTAZIDIME FOR INJECTION, USPCEFTAZIDIME6 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Beta-lactam antibiotics - Assessing the potential risk of severe skin side effects

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: